genprowebdirectory
News
Insights
A-Lists
Topics
Bioprocessing
Cancer
Drug Discovery
OMICs
Translational Medicine
Genome Editing
Magazine
Resources
Posters
Videos
Webinars
eBooks
Podcasts
Events
New Products
Tutorial
Best of the Web
Best Apps
Subscribe
Create a Free Account
Log In
Get GEN Magazine
Get GEN eNewsletters
Get the GEN Mobile App
Get GEN News from Alexa
Search
Search
Advertising
Magazine Advertising
Website Banner Advertising
eNewsletter Advertising
Webinar Sponsorship
eBook Advertising
Email Nurture Campaigns
Ad Terms and Conditions
About GEN
Contact GEN
Create a Free Account
Log In
GEN – Genetic Engineering and Biotechnology News
Mary Ann Liebert, Inc. Publishers
News
Boehringer Ingelheim
Boehringer Ingelheim Launches Up-to-€1.1B IPF Collaboration with Bridge Biotherapeutics
Neuroscience
Literal Window into the Brain Shows How to Induce Illusions in…
GWAS
GWAS Discovers New Type 2 Diabetes Gene in African Population
News
Aggressive Prostate Cancer Metastasis Mechanisms Uncovered
Aging
Is the Epigenome the Secret to Longevity…in Fruit Flies?
Insights
Insights
Top 10 Biopharma IPOs of January–June 2019
Tech Exclusives
A Toolbox for Keeping CRISPR in Check
Tech Exclusives
Drones Land in the Cell and Gene Therapy Space
Tech Exclusives
An Integrated Digital Vision for Biomanufacturing’s Future
Tech Exclusives
CRISPR and LASER ART Eliminate HIV from Mice
A-Lists
Insights
Top 10 Biopharma IPOs of January–June 2019
Insights
Top 10 M&A Deals of January–June 2019
Insights
The Top 10 Highest-Paid Women Executives in Biopharma
Insights
Top 50 NIH-Funded Institutions of 2019
July 2019 Vol. 39 No. 7
25 Up-and-Coming Gene Therapies of 2019
Topics
All
Bioprocessing
Cancer
Drug Discovery
OMICs
Translational Medicine
Genome Editing
Neuroscience
Literal Window into the Brain Shows How to Induce Illusions in…
GWAS
GWAS Discovers New Type 2 Diabetes Gene in African Population
News
Aggressive Prostate Cancer Metastasis Mechanisms Uncovered
Aging
Is the Epigenome the Secret to Longevity…in Fruit Flies?
Magazine
July 2019 Vol. 39 No. 7
CRISPR-Accelerated Gene Drives Pump the Brakes
July 2019 Vol. 39 No. 7
CRISPR Cinema: Scenes from the Cutting Edge
Tech Exclusives
Immunotherapy Targets Emerging Infectious Diseases
July 2019 Vol. 39 No. 7
Single-Cell Sequencing Sifts through Multiple Omics
Tech Exclusives
Bioreactor Design Adapts to Biopharma’s Changing Needs
Resources
All
Posters
Videos
Webinars
eBooks
Podcasts
Events
New Products
Tutorial
Best of the Web
Best Apps
GENcast
GENcast: Precision Health’s Bloodline Starts with Great Science
GENcast
GENcast: A Biological GPS That Guides Awareness through Cellular Space
July 2019 Vol. 39 No. 7
Full-Length Transcript Sequencing—No Assembly Required
July 2019 Vol. 39 No. 7
Plasma Proteomics with NanoLC-MS
Subscribe
Create a Free Account
Log In
Get GEN Magazine
Get GEN eNewsletters
Get the GEN Mobile App
Get GEN News from Alexa
Search
Home
Rare and Neglected Diseases
Rare and Neglected Diseases
Latest
Latest
Featured posts
Most popular
7 days popular
By review score
Random
Rare and Neglected Diseases
Acer Therapeutics Axes 60% of Workforce after FDA Rebuff
Rare and Neglected Diseases
Amicus, Thermo Fisher’s Brammer Bio Partner on Gene Therapy Manufacturing
Rare and Neglected Diseases
Vertex Grows Gene Editing Presence, Acquiring Exonics and Expanding CRISPR Therapeutics Collaboration
Rare and Neglected Diseases
Orchard Therapeutics Licenses MPS-I Gene Therapy from SR-TIGET
Rare and Neglected Diseases
Gilead Sciences Launches Up-to-$2B Kidney Disease Partnership with Goldfinch Bio
Rare and Neglected Diseases
Pfizer to Acquire Therachon for Up to $810M, Expanding Rare Disease...
Rare and Neglected Diseases
Takeda Inks Licensing Option Agreement with Gene Editing Platform Developer Emendo
Rare and Neglected Diseases
Alexion Inks Collaborations Totaling $1.3B+ with Affibody, Zealand
Rare and Neglected Diseases
Pfizer Gains Option to Buy Rare Disease Gene Therapy Developer Vivet...
Rare and Neglected Diseases
Roche-Licensed Rare Disease Drug at Center of Ipsen’s Up-to-$1.3B Clementia Acquisition
Rare and Neglected Diseases
Wilson among Co-Founders of Gene Therapy Developer Launched with $115.5M
Rare and Neglected Diseases
Sangamo Shares Plunge after Interim Results for MPS Candidates Fall Short...
Rare and Neglected Diseases
Licensing Deal Moves Merck KGaA, Vertex Further into Gene Editing-Based Drug...
Rare and Neglected Diseases
Orchard Therapeutics Plans 3 Approval Submissions, In-House Manufacturing by 2021
Rare and Neglected Diseases
Customer Insights: Roivant Scales up Bioprocesses through a CDMO
Load more
Scroll Up
We use cookies to give you a better experience on genengnews.com. By continuing to use our site, you are agreeing to the use of cookies as set in our
privacy policy.
Got it!
Edit with Live CSS
